Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Daxor Corporation

DXR
Current price
9.01 USD +0.19 USD (+2.15%)
Last closed 9.23 USD
ISIN US2394671034
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 45 835 368 USD
Yield for 12 month +14.78 %
1Y
3Y
5Y
10Y
15Y
DXR
21.11.2021 - 28.11.2021

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh. Address: 109 Meco Lane, Oak Ridge, TN, United States, 37830

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

23.38 USD

P/E ratio

8.1638

Dividend Yield

Current Year

+34 590 261 USD

Last Year

+6 310 294 USD

Current Quarter

+35 878 USD

Last Quarter

+35 878 USD

Current Year

+34 413 186 USD

Last Year

+6 310 294 USD

Current Quarter

-54 361 USD

Last Quarter

+35 878 USD

Key Figures DXR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM -419.25 %
PE Ratio 8.1638
Return On Assets TTM -1.4 %
PEG Ratio
Return On Equity TTM 5.35 %
Wall Street Target Price 23.38 USD
Revenue TTM 154 205 USD
Book Value 6.75 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -11.4 %
Dividend Yield
Gross Profit TTM 231 641 USD
Earnings per share 1.16 USD
Diluted Eps TTM 1.16 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -57.6 %
Profit Margin 1094 %

Dividend Analytics DXR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History DXR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 05.01.2018
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date 12.01.2018

Stock Valuation DXR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 8.1638
Forward PE
Enterprise Value Revenue 18.2249
Price Sales TTM 297.2366
Enterprise Value EBITDA
Price Book MRQ 1.4036

Financials DXR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DXR

For 52 weeks

7.11 USD 10.04 USD
50 Day MA 9.04 USD
Shares Short Prior Month 15 861
200 Day MA 8.95 USD
Short Ratio 1.84
Shares Short 13 028
Short Percent 0.62 %